Lenalidomide
| CAS No. | 191732-72-6 | Cat. No. | BCP01390 |
| Name | Lenalidomide | ||
| Synonyms | CC-5013;CC 5013;CC5013; | ||
| Formula | C13H13N3O3 | M. Wt | 259.26 |
| Description | Lenalidomide, also known as CC-5013, is the thalidomide analog with potential antineoplastic activity. Lenalidomide inhibits TNF-alpha production, stimulates T cells, reduces serum levels of the cytokines vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), and inhibits angiogenesis. This agent also promotes G1 cell cycle arrest and apoptosis of malignant cells. | ||
| Pathways | Apoptosis Pathway | ||
| Targets | TNF Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.